^
Association details:
Evidence:
Evidence Level:
Resistant: C4 – Case Studies
Source:
Title:

RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance

Published date:
10/03/2019
Excerpt:
Moreover, RPL22L1 protein is highly expressed in patient CRC samples and correlates with poor survival. Interestingly, the association of high RPL22L1 expression with poor prognosis appears to be linked to resistance to 5-Fluorouracil...
DOI:
10.1371/journal.pone.0222392